SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001019231-21-000007
Filing Date
2021-02-16
Accepted
2021-02-16 13:35:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 taysha13g.htm SC 13G 7821
  Complete submission text file 0001019231-21-000007.txt   9419
Mailing Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701
Business Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701 5122251630
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by) CIK: 0001019231 (see all company filings)

IRS No.: 742765082 | State of Incorp.: TX | Fiscal Year End: 0831
Type: SC 13G

Mailing Address 2280 INWOOD ROAD DALLAS TX 75235
Business Address 2280 INWOOD ROAD DALLAS TX 75235 (214) 612-0000
Taysha Gene Therapies, Inc. (Subject) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91724 | Film No.: 21635711
SIC: 2836 Biological Products, (No Diagnostic Substances)